BackCardio Diagnostics Holdings- Warrants (01/12/2026) Overview

Cardio Diagnostics Holdings- Warrants (01/12/2026) Total Liabilities

Track Cardio Diagnostics Holdings- Warrants (01/12/2026)'s total liabilities ($660K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$655972.00
27.52% YoYΔ $-249026.00 vs prior year quarter

Peer average

Loading

Cardio Diagnostics Holdings- Warrants (01/12/2026) Total Liabilities History

Loading

Cardio Diagnostics Holdings- Warrants (01/12/2026) vs. peers: Total Liabilities Comparison

Loading

Cardio Diagnostics Holdings- Warrants (01/12/2026) Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Cardio Diagnostics Holdings- Warrants (01/12/2026) (CDIOW) FAQ

Cardio Diagnostics Holdings- Warrants (01/12/2026) posts a total liabilities of $660K as of March 2026. That compares with $900K in the prior-year period — down 27.5% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Cardio Diagnostics Holdings- Warrants (01/12/2026)'s total liabilities was $900K. The latest reading is $660K — a 27.5% year-over-year decrease (period ending March 2026). Use the history and growth charts on this page for a longer lookback.

Total Liabilities is one piece of Cardio Diagnostics Holdings- Warrants (01/12/2026)'s financial statement story. At $660K, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for CDIOW's total liabilities usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Cardio Diagnostics Holdings- Warrants (01/12/2026)'s other metric pages and overview cover the third.